Other News To Note
Tuesday, October 30, 2012
Cellectis SA, of Paris, presented data at the European Society of Gene & Cell Therapy meeting in Versailles, France, showing that it can program cells from the immune system (T cells) to kill cancer cells. Cellectis' approach involves isolating cells from the immune systems of healthy patients and genetically programming them to attack cancer cells in sick patients.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.